Novozymes CSO buys stock for more than EUR 110,000

The company's chief science officer and SVP of R&D took over 2,100 shares in the firm on Thursday.

Photo: Novozymes/PR

Claus Crone Fuglsang, chief science officer and senior vice president of research and development at Novozymes, bought 2,110 shares in the Danish enzyme group on Thursday at an average share price of DKK 387.93.

The total share purchase thereby comes to DKK 818,525.60 (EUR 110,012.09), according to a statement by Novozymes Thursday evening CET.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Related articles

Latest News


See all

See all